130 related articles for article (PubMed ID: 10543424)
1. Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP.
Akinshola BE; Taylor RE; Ogunseitan AB; Onaivi ES
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):242-8. PubMed ID: 10543424
[TBL] [Abstract][Full Text] [Related]
2. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes.
Oz M; Zhang L; Morales M
Synapse; 2002 Dec; 46(3):150-6. PubMed ID: 12325042
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD
Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365
[TBL] [Abstract][Full Text] [Related]
4. Ethanol sensitivity of recombinant homomeric and heteromeric AMPA receptor subunits expressed in Xenopus oocytes.
Akinshola BE; Yasuda RP; Peoples RW; Taylor RE
Alcohol Clin Exp Res; 2003 Dec; 27(12):1876-83. PubMed ID: 14691374
[TBL] [Abstract][Full Text] [Related]
5. Thiocyanate ions inhibit AMPA-activated currents in recombinant non-NMDA receptors expressed in Xenopus laevis oocytes: the role of the GluR2 subunit.
Eugène D; Moss SJ; Smart TG
Eur J Neurosci; 1996 Sep; 8(9):1983-93. PubMed ID: 8921289
[TBL] [Abstract][Full Text] [Related]
6. The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.
Oz M; Yang KH; Dinc M; Shippenberg TS
J Pharmacol Exp Ther; 2007 Nov; 323(2):547-54. PubMed ID: 17682128
[TBL] [Abstract][Full Text] [Related]
7. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
Ameri A; Wilhelm A; Simmet T
Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
[TBL] [Abstract][Full Text] [Related]
8. CB1 cannabinoid receptor-mediated cell migration.
Song ZH; Zhong M
J Pharmacol Exp Ther; 2000 Jul; 294(1):204-9. PubMed ID: 10871313
[TBL] [Abstract][Full Text] [Related]
9. In-vitro and in-vivo action of cannabinoids.
Akinshola BE; Chakrabarti A; Onaivi ES
Neurochem Res; 1999 Oct; 24(10):1233-40. PubMed ID: 10492518
[TBL] [Abstract][Full Text] [Related]
10. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.
Nicholson RA; Liao C; Zheng J; David LS; Coyne L; Errington AC; Singh G; Lees G
Brain Res; 2003 Jul; 978(1-2):194-204. PubMed ID: 12834914
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system.
McAllister SD; Griffin G; Satin LS; Abood ME
J Pharmacol Exp Ther; 1999 Nov; 291(2):618-26. PubMed ID: 10525080
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
Kim D; Thayer SA
J Neurosci; 2001 May; 21(10):RC146. PubMed ID: 11319244
[TBL] [Abstract][Full Text] [Related]
13. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses.
Bonhaus DW; Chang LK; Kwan J; Martin GR
J Pharmacol Exp Ther; 1998 Dec; 287(3):884-8. PubMed ID: 9864268
[TBL] [Abstract][Full Text] [Related]
14. Direct noncompetitive inhibition of 5-HT(3) receptor-mediated responses by forskolin and steroids.
Oz M; Zhang L; Spivak CE
Arch Biochem Biophys; 2002 Aug; 404(2):293-301. PubMed ID: 12147268
[TBL] [Abstract][Full Text] [Related]
15. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission.
Hampson AJ; Bornheim LM; Scanziani M; Yost CS; Gray AT; Hansen BM; Leonoudakis DJ; Bickler PE
J Neurochem; 1998 Feb; 70(2):671-6. PubMed ID: 9453561
[TBL] [Abstract][Full Text] [Related]
16. The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes.
Oz M; Ravindran A; Diaz-Ruiz O; Zhang L; Morales M
J Pharmacol Exp Ther; 2003 Sep; 306(3):1003-10. PubMed ID: 12766252
[TBL] [Abstract][Full Text] [Related]
17. The aniracetam metabolite 2-pyrrolidinone induces a long-term enhancement in AMPA receptor responses via a CaMKII pathway.
Nishizaki T; Matsumura T
Brain Res Mol Brain Res; 2002 Jan; 98(1-2):130-4. PubMed ID: 11834304
[TBL] [Abstract][Full Text] [Related]
18. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.
Mackie K; Devane WA; Hille B
Mol Pharmacol; 1993 Sep; 44(3):498-503. PubMed ID: 8371711
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
[TBL] [Abstract][Full Text] [Related]
20. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
